Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share News

12

IN BRIEF: CRISM Therapeutics starts patient recruitment for study

21st Aug 2026 18:26

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - On Thursday, announced that the first clinical site for its phase 2 study of irinotecan ChemoSeed for the treatment of glioblastoma has now been formally activated and patient recruitment has started. CRISM says formal site activation is "a significant milestone" for ChemoSeed's clinical development programme. It enables the clinical team to start identifying, screening and enrolling eligible patients into the study. Read More

TRADING UPDATES: TPXimpact wins Ministry of Justice contract

13th Aug 2026 19:48

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS: CRISM, Ampeak and Ethtry widen 2025 pretax loss

26th Jun 2026 10:29

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Caspian reports progress; Arkle nears Erongo drilling

25th Jun 2026 18:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

8th Jun 2026 12:28

Read More

EARNINGS AND TRADING: CRISM wins "highly competitive" UK grant

4th Jun 2026 13:37

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS & TRADING: MP Evans restarts buybacks with new programme

26th May 2026 18:15

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: capAI hails outlook; Intercede wins new orders

21st Apr 2026 18:30

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Nichols trades in line; Crest Nicholson slumps

21st Apr 2026 11:33

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

TRADING UPDATES: RWS launches AI offering; SulNOx patent wins

25th Mar 2026 16:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Volex beats consensus; Asos backs outlook

25th Mar 2026 11:10

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

AIM WINNERS & LOSERS: CRISM rises; Intercede warns on earnings miss

17th Mar 2026 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

TRADING UPDATES: Netcall acquires Jadu for up to GBP19 million

10th Dec 2025 16:16

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

CRISM reports "significant" preclinical data for prostate cancer drug

14th Oct 2025 16:50

(Alliance News) - CRISM Therapeutics Corp said on Tuesday that preclinical studies show that its ChemoSeed drug delivery platform could "could substantially enhance" the efficacy of docetaxel in the treatment of prostate cancer. Read More

EARNINGS: CRISM loss widens as "actively" prepares for phase 2 trial

15th Sep 2025 21:41

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: CRISM confident in ChemoSeed as targets trial approval

26th Aug 2025 13:56

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - As the firm held its annual general meeting, Chair Nermeen Varawalla says the firm must attract, retain and incentivise the best people as it continues to seek further validation for its novel delivery method. "[We] are confident that ChemoSeed has the potential to transform treatment for patients with solid-tumour cancers," Chair Varawalla continues. ChemoSeed is an implantable biodegradable drug delivery technology designed for the sustained delivery of chemotherapy directly into cancer tissue. Chair Varawalla says the company is focused on gaining trial approval from the UK Medicines & Healthcare products Regulatory Agency in glioblastoma and progressing towards dosing first patients in early 2026. Read More

UK shareholder meetings calendar - next 7 days

19th Aug 2025 14:58

Read More

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations

30th Jun 2025 12:01

(Alliance News) - London stocks were mixed at midday on Monday, as US tariff uncertainty continues to weigh on investor sentiment despite a data reading confirming UK economic growth at the start of the year. Read More

AIM WINNERS & LOSERS: MediaZest swings to profit, remains optimistic

30th Jun 2025 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More

CRISM Therapeutics hails progress in glioblastoma as loss widens

13th Jun 2025 09:43

(Alliance News) - CRISM Therapeutics Corp on Friday said it is confident in its prospects, citing progress in glioblastoma, as it reported an increased loss. Read More

12
FTSE 100 Latest
Value10,816.56
Change68.40